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Four binuclear copper (II) complexes [Cu(oxpn)Cu(B)]2+ (2–5) bridged by N, N0-bis[3-(methylamino)
propyl] oxamide (oxpn), where, B is N, N-donor heterocyclic bases (viz. 2,20-bipyridine (bpy, 2), 1,10-
phenathroline (phen, 3), dipyrido[3,2-d:20,30-f]quinoxaline (dpq, 4) and dipyrido[3,2-a:20 ,30-c]phenazine
(dppz, 5) are synthesized, characterized by different spectroscopic and single crystal X-ray data
technique. The phen (3) and dpq (4) complexes were structurally characterized by X-ray data analysis.
Their DNA binding, oxidative cleavage and antibactirial activities were studied. The dpq (4) and dppz
(5) complexes are avid binders to the Calf thymus DNA (CT-DNA). The phen (3), dpq (4) and dppz (5)
complexes show efﬁcient oxidative cleavage of supercoiled DNA (SC DNA) through hydroxyl radical
(OH) pathway in the presence of Mercaptopropionic acid (MPA).
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Recent progress in structure-based design of molecules targeted
towards DNA cleavage show that the promise of this area as a
source of novel therapeutic agents and continued as a vibrant area
of research. Substantial progress has been made over the past cou-
ple of decades in the fundamental characterization of a variety of
drug-DNA interactions [1–10]. The interaction of transition metal
complexes with dioxygen in the presence of a reducing or oxidiz-
ing agent generates reactive oxygen species (ROS) that ultimately
cleave DNA [7]. Oxidative DNA cleavage by redox-active metal
complexes like [Fe(edta)]2 or Cu(1,10-phenanthroline)2Cl2 is
mediated by the production of reactive oxygen species, like HO
through a Fenton-type mechanism [10]. These free radicals
abstract the most accessible and exposed sugar hydrogen’s and
initiate the oxidative cleavage, leading to DNA scision.
Binuclear copper complexes are attracting much attention [11],
because of their spin–spin coupling, selective binding to particular
conformations of nucleic acid and efﬁcient intramolecular activa-
tion of bound O2 in DNA cleavage [12,13]. Incorporation of two
or more Cu(II) centers in a single compound produces enhanced
electrostatic interactions to the anionic DNA phosphate backbone
and facilitates its binding to DNA [14]. The Cu(II) centers in closeproximity may undergo multielectron reductive cleavage of O2 to
generate an equivalent amount of hydroxyl radicals (HO) [15].
These features were excellently demonstrated by examples re-
ported by Karlin et al., using polynuclear Cu(II) complexes
[14,16,17]. Binuclear metal complexes with extended bridged
structures exhibit spin exchange and charge transfer between me-
tal ions [18–21], when such coordination complexes contains DNA-
binding moiety that binds either at a groove, or as an intercalator,
increases the DNA-targeting ability of the compound. Many metal-
loproteins and enzymes have multi-metal sites, which are essential
for their biological and catalytic function. Few reports have been
published which are devoted only to the synthesis of oxamido
binuclear metal complexes [22] and no reports with DNA interac-
tion studies of oxamido metal complexes.
An enzyme Catechol oxidases contain two Cu centers in their
active site, catalyzes the two-electron oxidation of a broad range
of o-diphenols (catechols). In sweet potato, two cupric ions of cat-
echol oxidase bridged by hydroxo ligand [23]. The development of
synthetic analogues of metalloenzymes containing dinuclear Cu
centers has become an attractive approach to understand the
mechanisms involved in bio-catalytic pathways. The present work
stems from our interest to design and develop 3d-metal complexes
that could cleave DNA in an oxygen independent pathway [29–31].
Herein, we report the syntheses, structure, DNA binding, oxida-
tive DNA cleavage activity and antimicrobial activity of l-oxamido
ternary copper (II) complexes i.e. [Cu(oxpn)(B)]+ (1–5) where B is
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dppz (5). The phen (3) and dpq (4) complexes have been structur-
ally characterized by single crystal X-ray data. Studies have been
made to explore the role of DNA binder and oxpn along with mech-
anistic pathway involved in the ‘chemical nuclease’ activity.2. Experimental
2.1. Materials
All chemicals and reagents were obtained from commercial
sources and were used without further puriﬁcation. Solvents used
for electrochemical and spectroscopic studies were puriﬁed by
standard procedures [24]. The supercoiled pUC19 DNA (CsCl puri-
ﬁed) was purchased from Bangalore Genei (India). Calf thymus (CT)
DNA, Agarose (molecular biology grade), Distamycin-A, Catalase,
Superoxide dismutase (SOD), Mercaptopropionic acid (MPA) and
Ethidium bromide (EB) were obtained from Sigma (USA). Tris
(hydroxymethyl) aminomethane-HCl (Tris–HCl) buffer solution
was prepared by using deionized, sonicated triple distilled water.
The N, N-donor heterocyclic base dipyrido[3,2-d:20,30-f]quinoxa-
line (dpq) and dipyrido[3,2-a:20,30-c]phenazene (dppz) ligands
were prepared by literature procedure using 1,10-phenanthro-
line-5, 6-dione as a precursor reacted with ethylenediamine and
o-phenyl diamine [25].2.2. Synthesis of Cu(oxpn (1), [Cu2(oxpn)2(B)]n+ where B = bpy (2),
phen (3), dpq (4), dppz (5)
A solution of 0.1 mol of diethyl oxalate in 20 ml ethanol was
added dropwise to a solution of 0.3 mol of 1, 3-propylenediamine
in 30 ml ethanol cooled by an ice bath. The resulting solution
was reﬂuxed for 1 h and then cooled down. A 0.75 mol Cu(OH)2
suspended in 500 ml of water was added, which led to formation
of a violet solution and a brown solid. Red single crystals of
Cu(oxpn) were obtained after evaporation of the solvent, it is solu-
ble in water and insoluble in alcohol [26].
A 100 ml aqueous solution of 216 mg (1 mM) of Cu(oxpn) were
successively added to 10 ml of an aqueous solution containing
371 mg (1 mM) of copper (II) perchlorate hexahydrate and 10 ml
of an aqueous solution containing 158 mg (1 mM) of bpy (2),
198 mg phen (3), 232 mg dpq (4) and 282 mg dppz (5), on slow
evaporation yields dark brown crystals and ﬁnally dried over
P4O10 (Yield: 75%).
Anal. Calc. for (1): C8H16CuN4O2(M.W. 263.5) C, 36.43; H, 6.07;
N, 21.25. Found: C, 36.44; H, 6.08; N, 21.22. kmax, nm (e, M1 cm1)
in water/DMF(5%): 764 (24), 757 (240), 729 (25), 532 (68), 231
(1913). FT-IR, cm1 (KBr disc): 3398w, 3191s, 3124s, 2906m,
2875m, 2842m, 1585vs, 1359s, 1190m, 1151m, 1047m, 952s,
826m, 717m, 443s, (s, strong; m, medium; w, weak; vs very
strong).
Anal. Calc. for (2): C18H24Cu2N6O10Cl2 (M.W. 682.5) C, 31.67; H,
3.51; N, 12.31. Found: C, 31.65; H, 3.47; N, 12.28%. kmax, nm (e,
M1 cm1) in water/DMF(5%): 776 (3440), 764 (3462), 605 (314),
570 (36032), 550 (373), 534 (199), 377 (107), 359 (812), 291
(30207), 283 (11791). FT-IR, cm1 (KBr disc): 3413m, 3326m,
3276m, 2925m, 1629s, 1448s, 1348w, 1313w, 1089vs, 933w,
779m, 730m, 626m, 437w. KM (X1 cm2 M1) in DMF at 25 C:
112.
Anal. Calc. for (3) C40H49Cu4N12O22Cl4 (M.W. 1444.6): C, 33.20;
H, 3.39; N, 11.62. Found: C, 33.18; H, 3.44; N, 11.57%. kmax, nm
(e, M1 cm1) in water/DMF(5%): 626 (72), 602 (65), 376 (903),
232 (1356), 208 (1168), FT-IR, cm1 (KBr disc): 3413m, 3265w,
2927w, 1629s, 1431m, 1344m, 1089vs (ClO4), 931w, 858m,
723m, 626m, 437w. KM (X1 cm2 M1) in water at 25 C: 251.Anal. Calc. for (4) C22H26Cu2N8O11Cl2 (M.W. 775.5): C, 34.04; H,
3.22; N, 14.44. Found: C, 34.07; H, 3.22; N, 14.42%. kmax, nm (e,
M1 cm1) in water/DMF(5%): 604 (55), 310 (13,420), 300
(13,620), 243 (10,220). FT-IR, cm1 (KBr disc): 3429m, 2931m,
2854w, 1629s, 1446s, 1406m, 1346w, 1311w, 1087vs, 933w,
825w, 732w, 630s, 437 m.KM (X1 cm2 M1) in DMF at 25 C: 109.
Anal. Calc. for (5) C26H27Cu2N8O11Cl2 (M.W. 825.5): C, 37.79; H,
3.22; N, 14.44. Found: C, 37.43; H, 3.33; N, 14.43%. kmax, nm (e,
M1 cm1) in water: 611 (55), 293 (8,320), 272 (27,620), 204
(38,660). FT-IR, cm1 (KBr disc): 3434m, 3276w, 3236w, 3139w,
2933m, 1629vs, 1444s, 1402m, 1087vs, 831m, 734m, 626m,
547w, 437m. KM (X1 cm2 M1) in DMF at 25 C: 118.
2.3. General methods
The elemental analysis was done using a Thermo Finnigan
FLASH EA 1112 CHNS analyzer. The infrared and electronic spectra
were recorded on Perkin Elmer spectrum one 55 spectrophotome-
ters and Perkin Elmer Lambda 35 respectively. DNA melting exper-
iments were carried out on a Varian Cary 300 Bio UV–Vis
spectrophotometer attached to a Cary Peltier temperature control-
ler. Molar conductivity measurements were done using a Control
Dynamics (India) conductivity meter. Electrochemical measure-
ments were made at 25 C on an EG&G PAR model 253 VersaStat
potentiostat/galvanostat with electrochemical analysis software
270 using a three electrode setup consisting of a glassy carbon
working, platinum wire auxiliary and a saturated calomel refer-
ence electrode (SCE) in DMF containing 0.1 M Tetrabutylammo-
nium perchlorate (TBAP). The electrochemical data were
uncorrected for junction potentials.
2.4. X-ray crystallographic procedures
Single crystals of complex 3 and 4 were obtained by slow evap-
oration of the aqueous-methanolic solution of the complexes. A
rectangular single crystal was mounted on a glass ﬁber and used
for data collection. All geometric and intensity data were collected
at 293 K using an automated Bruker SMART APEX CCD diffractom-
eter equipped with a ﬁne focus 1.75 kW sealed tube Mo Ka X-ray
source (k = 0.71073 Å), with increasing x (width of 0.3/frame) at
a scan speed of 5 and 2 s/frame for complex 3 and 4 respectively.
Intensity data, collected using x – 2h scan mode, were corrected
for Lorentz-polarization effects and for absorption [27]. The SMART
software was used for data acquisition and the SAINT software for
data extraction [28]. Absorption corrections were made using SAD-
ABS [29]. The structure was solved and reﬁned by full-matrix
least-squares method using SHELX system of programs [30]. All
non-hydrogen atoms were reﬁned anisotropically. All hydrogen
atoms attached to the heteroatoms were in their calculated posi-
tions and reﬁned using a riding model. Perspective views of the
complexes were obtained by ORTEP [31]. CCDC reference numbers
806157 and 806156 for complex 3 and 4 respectively.
2.5. DNA binding experiments
In the UV–visible absorption titration experiments, absorbance
at 260 and 280 nm for CT-DNA in 5 mM Tris–HCl buffer (pH 7.2)
gave a ratio of 1.9:1, indicating the DNA free of protein [32]. The
concentration of CT-DNA was measured from the band intensity
at 260 nm with a known e value (6600 M1 cm1) [33]. Absorption
titration measurements were done by varying the concentration of
CT-DNA keeping the complex concentration(40 lM) constant in
5 mM Tris–HCl/5 mM NaCl buffer (pH 7.2). The intensity of the
band at 260 nm was monitored for the complexes. Correction
was made for the absorption of DNA itself. The spectra were re-
corded after equilibration for 5 min, allowing the complexes to
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(Kb) values of the complexes to CT-DNA were obtained by
McGhee–von Hippel (MvH) method using the expression of Bard
and coworkers by monitoring the change in the absorption inten-
sity [34].
The apparent binding constant (Kapp) values of the complexes
were determined by ﬂuorescence spectral technique using EB
bound CT-DNA solution in Tris–HCl/NaCl buffer (pH, 7.2). The
emission intensities of EB at 600 nm (546 nm excitation) with an
increasing amount of the complex concentration were recorded.
The Kapp values were obtained from equation: Kapp[complex]50 =
KEB[EB], where, Kapp is the apparent binding constant of the com-
plex studied, [complex]50 is the concentration of the complex at
50% quenching of DNA bound EB emission intensity, KEB is the
binding constant of EB(KEB = 1.0  107 M1) and [EB] is the concen-
tration of ethidium bromide (1.3 M). EB was non-emissive in
Tris-buffer medium due to ﬂuorescence quenching of the free EB
by the solvent molecules [35]. In the presence of DNA, EB showed
enhanced emission intensity due to its intercalative binding to
DNA. A competitive binding of the coper complexes to CT-DNA
could result in the displacement of EB or quenching of the bound
EB by the paramagnetic copper (II) species decreasing its emission
intensity.
DNA-melting experiments were carried out by monitoring the
absorbance of CT-DNA (200 lM nucleobase pair (NP) at 260 nm
with varying temperature in the absence and presence of the com-
plexes in a 2:1 ratio of DNA–Complex with a ramp rate of
0.5 C min1 in phosphate buffer (pH 6.85) using a Peltier system
attached to the UV–Vis spectrophotometer.
Viscometric titrations were performed with a Schott Gerate AVS
310 Automated Viscometer. The viscometer was thermostated at
37 C in a constant temperature bath. The concentration of DNA
was 200 M in nucleobase pair (NP) and the ﬂow times were mea-
sured with an automated timer and each sample was measured 3
times and an average ﬂow time was calculated. Data were pre-
sented as (g/g0)1/3 vs. [complex]/[DNA], where g is the viscosity
of DNA in the presence of complex and 0 that of DNA alone. Viscos-
ity values were calculated from the observed ﬂowing time of DNA-
containing solutions (t) corrected for that of buffer alone (t0), g = (t
 t0) [36].2.6. DNA cleavage experiments
The extent of cleavage of supercoiled (SC) DNA in the presence
of the complex and reducing agent MPA was determined by aga-
rose gel electrophoresis. In a typical reaction, supercoiled pUC19
DNA (0.2 lg), taken in 50 mM Tris–HCl buffer (pH 7.2) containing
50 mM NaCl, was treated with the complex. The extent of cleavage
was measured from the intensities of the bands using UVITEC Gel
Documentation System.
For mechanistic investigations, inhibition reactions were done
on adding the reagents prior to the addition of the complex. The
solutions were incubated for 1 h in a dark chamber at 37 C fol-
lowed by addition of the loading buffer containing 0.25% bromo-
phenol blue, 0.25% xylene cyanol and 30% glycerol (2 lL) and the
solution was ﬁnally loaded on 1.0% agarose gel containing 1.0 lg/
ml EB. Electrophoresis was carried out for 2 h at 60 V in tris–ace-
tate-EDTA (TAE) buffer. Bands were visualized by UV light and
photographed for analysis. Due corrections were made to the ob-
served intensities for the low level of NC form present in the origi-
nal sample of SC DNA and for the low afﬁnity of EB binding to SC in
comparison to nicked circular (NC) and linear forms of DNA [37].
The concentration of the complexes or the additives mentioned
corresponded to the quantity of the sample in 2 lL stock solution
prior to dilution to the 20 lL ﬁnal volume by Tris–HCl buffer.2.7. Antimicrobial activity
The antibacterial activity was tested against clinical isolates like
B. subtilis, Micrococcus luteus, Staphylococcus aureus, Staphylococcus
mutans, Escherichia coli, Pseudomonas aeruginosa and Proteus vulga-
ris. The test organisms were maintained on nutrient agar slants. In
vitro antibacterial activity was determined by the agar well-diffu-
sion method as described by Mukherjee et al. [38]. The overnight
bacterial culture was centrifuged at 8000 rpm for 10 min. The bac-
terial cells were suspended in saline to make a suspension of
105 CFU/mL and used for assay. Plating was carried out by trans-
ferring the bacterial suspension to a sterile Petri plate, mixed with
molten nutrient agar medium and allowed to solidify. About 75 lL
of the sample (2 mg/mL) was placed in the wells. Plates were incu-
bated at 37 C and activity was determined by measuring the
diameter of the inhibition zones. The assay was carried out in trip-
licate. The minimum inhibitory concentration (MIC) values were
determined according to the method described by Jones et al. [39].
Different concentrations of the compounds and 100 ll of the
bacterial suspension (105 Colony-forming unit (CFU)/mL)) were
placed aseptically in 10 ml of nutrient broth separately and incu-
bated for 24 h at 37 C. Growth was observed at regular intervals
followed by pour plating as described above. The lowest concentra-
tion of the test sample showing no visible growth was recorded as
the MIC. Triplicate sets of tubes were maintained for each concen-
tration of test sample.3. Results and discussion
3.1. Synthesis and general aspects
The binuclear copper (II) complexes were prepared in high yield
from the reaction of Cu(oxpn) and Cu(ClO4)27H2O with heterocy-
clic bases. The complexes are stable and soluble in common polar
organic solvents. They are characterized from the analytical and
physicochemical data (Table 1, Scheme 1). The complexes display
intense charge transfer band in the range of 200–310 nm that
can be attributed to the p? p⁄ transition of the coordinated N,
N-donor heterocyclic base. The d–d band is observed at 600 nm
in an aqueous medium (Fig. 1). All the complexes exhibit strong
absorption peak between 200–275 cm1 attributable to plane ring
vibrations. The bands between 300–400 cm1 may be assigned to
ring and metal–nitrogen vibrations. All the complexes are showing
a characteristic perchlorate peak at 1087–1089 cm1 (mClO4). The
coordinated perchlorate shoulder peaks appear at 1035,
1143 cm1 on either sides of characteristic perchlorate peak
(Figs. S1, S2). Complexes 1–5 are redox active showing cyclic vol-
tammetric responses involving the metal center and the ligands
in DMF-0.1 M TBAP (Table 1, Fig. S3). Anodic response (Epa) is ob-
served near 0.540 V and with cathodic counterpart (Epc) at ca.
0.589 V. The anodic response is assigned to the Cu(II)/Cu(I) redox
couple showing a ipc/ipa peak current ratio of 0.904 (ipc, ipa are
cathodic and anodic peak currents, respectively). Copper (II) com-
plexes having readily accessible metal-based Cu(II)/Cu(I) redox
couple show signiﬁcant ‘‘chemical nuclease’’ activity in the pres-
ence of reducing thiols [40].3.2. Crystal structures
The phen and dpq complexes (3 and 4) are structurally charac-
terized using single-crystal X-ray diffraction technique. Selected
crystallographic data are summarized in Table 2. The selected bond
distances and angles present in 3 and 4 are shown in Table 3. OR-
TEP views of 3 and 4 are shown in Figs. 2 and 3 respectively. The 3
crystallizes in the monoclinic space group P21/c. In two different
Table 1
Physicochemical data for the ternary copper (II) complexes 1–5.
Complex 1 2 3 4 5
IRa: [m/cm1](ClO4) – 1089 1089 1089 1087
c(C@O) 1583 1629 1629 1629 1629
d–d band: kmax/nm (e/M1 cm1)b 538 (46) 605 (314) 602 (65) 541 (55) 583 (55)
CV: E1/2/V(DEp/mV)c 0.113 (1092) 0.034 (1126) 0.09 (1498) 0.025 (981) 0.55 (1096)
KM
d (X1 cm2 M1) – 112 (in DMF) 251 (in water) 109 (in DMF) 118 (in DMF)
Isosbestic (nm) Point 213, 274 – 243 247 –
a
e (M1) 2.51  105 3.5  106 5.5  106 7.86  106 9.76  106
Kb
f (M1) – 5.1  103 (±0.3) 1.14  105 (±0.2) 8.78  105 (±0.1) 2.24  106 (±0.3)
DTm
g (C) 0.5 (0.2) 0.8 (0.2) 1.4 (0.2) 1.8 (0.3) 2.4 (0.2)
a KBr phase.
b In aqueous medium.
c Cu(II)/Cu(I) couple inDMF-0.1 MTBAP. E1/2 = 0.5(Epa + Epc),DEp = |Epa – Epc|, where Epa and Epc are the anodic and cathodic peak potentials, respectively. Scan rate: 50 mVs1.
d In aqueous/DMF medium at 25 C.
e Apparent DNA binding constant from competitive binding assay by emission method.
f Intrinsic DNA binding constant (Kb) from absorption spectral method.
g Changes in melting temperature of CT DNA.
Scheme 1. Structures of the ternary copper (II) complexes (1–5) and phenanthro-
line bases.
Fig. 1. Electronic spectra of complexes 1–5 and the inset shows the d–d band of the
complexes.
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round the Cu were N4O1 + N2O2 and N2O3 + N4O1. The 4 crystallizes
in the monoclinic space group P21/n. It shows distorted square-
pyramidal (4 + 1) coordination (CuN4O and CuN2O3) geometry
with weakly coordinated apical perchlorate anions at both metal
centers. The Cu1–Cu2 separation within the binuclear cation is
5.196(1) Å. Average trigonal distortion parameter at Cu1 and Cu2
are 0.069 and 0.033 Å, respectively.
Both 3 and 4 show extensive intermolecular non-covalent
interactions. The unit cell packing diagrams and intermolecular
hydrogen bonding interactions present in 3 and 4 are shown in
Figs. S4–S7 (see Supporting information).3.3. DNA binding properties
Absorption titration technique has been used to monitor the
mode of interaction of the complexes 1–5.
Changes in the p?p⁄ transition of 1–5 in DMF/5 mM Tris–HCl/
50 mM NaCl buffer at pH 7.1 were determined as a function of in-
creased DNA concentration and the typical titration curve for 4 is
shown in Fig. 4. The intrinsic DNA binding constants (Kb) of the
complexes to CT-DNA are obtained by monitoring the change of
the absorption intensity of the spectral bands with increasing con-
centration of CT-DNA, keeping complex concentration constant.
The intrinsic equilibrium DNA binding constant (Kb) values of the
complexes are given in Table 1. The values of intrinsic binding con-
stants Kb determined from these changes follow the order
5 > 4 > 3 > 2. The dppz complexes show higher Kb values in com-
parison to their dpq and phen analogues possibly because of the
presence of an extended planar aromatic moiety in dppz which
facilitating non-covalent interactions with DNA. It primarily inter-
acts with the ds-DNA via intercalation and gets additional stabil-
ization by partial p-stacking interactions with the purine and
pyrimidine DNA bases [41].
The hypochromism was suggested to be due to a strong
interaction between the electronic states of the binding chromo-
phore and that of the DNA bases [42–45]. An isosbestic point at
243 nm were also observed indicating one mode of binding with
equilibrium between two species [44]. Complex 1 show two
isosbestic points at 213 and 274 nm, suggesting mixed modes of
DNA binding. The 3 show a single isosbestic point at 247 nm and
4 at 243 nm (Fig. S8).
We have used a ﬂuorescence spectral titration method to obtain
the apparent binding constant values (Kapp). The emission intensity
of EB is used as a spectral probe as EB shows no apparent mission
intensity in buffer solution because of solvent quenching and an
enhancement of the emission intensity when intercalatively bound
to DNA [46]. The ﬂuorescence intensities of EB at 600 nm (546 nm
excitation) with an increasing amount of the ternary complex con-
centration were recorded. In the presence of DNA, EB showed en-
hanced emission intensity due to its intercalative binding to
DNA. A competitive binding of the copper complexes to CT-DNA re-
sult in decrease of emission intensity. Relative binding propensity
of the complexes to DNA is measured from the extent of reduction
of the emission intensity (Fig. 5, Table 1).
The denaturation of DNA from double-strand to single strand
results in absorption hyperchromism around 260 nm. The binding
of metal complexes to the double-stranded DNA usually stabilizes
the duplex structure to some extent depending on the strength of
interaction with nucleic acid [47]. The binding should lead to an
Table 2
Selected main crystallographic data for 3 and 4.
3 4
Empirical formula C40H49Cl4Cu4N12O22 C22H25Cl2Cu2N8O11
Formula weight 1444.89 775.48
Crystal system monoclinic monoclinic
Space group P21/c P21/n
a (Å) 8.9133(2) 8.937(5)
b (Å) 24.4399(6) 11.986(5)
c (Å) 24.4409(5) 25.613(5)
b () 99.467(2) 93.123(5)
a = c () 90 90
V (Å3) 5251.7(2) 2740(2)
Z 4 4
T (K) 100(2) 100(2)
qcalcd (g cm3) 1.829 1.883
k Å (Mo Ka) 0.71073 0.71073
l (cm1) 1.894 1.825
Data/restraints/parameters 11418/0/407 5096/0/407
F(000) 2932 1598
Goodness-of-ﬁt 1.084 1.057
R (Fo)a, I > 2r(I)/wR (Fo)b 0.0483/ 0.1225 0.0261/0.0666
R (all data)/wR (all data) 0.0677/ 0.1264 0.0313/0.0678
Largest difference in peak and
hole (e Å3)
1.270 and 0.831 0.611 and 0.371
w = 1/[r2(Fo2) + (AP)2 + (BP)] A = 0.0503
B = 15.2520
A = 0.0354
B = 1.9640
a Denotes value of the residual considering only the reﬂections with I > 2r(I).
b Denotes value of the residual considering all the reﬂections.
Table 3
Selected bond distances and bond angles present in 3 and 4.
Complex 3 Complex 4
Cu01–O1 1.938 (3) Cu1–O1 2.583(2)
Cu01–O2 1.940 (3) Cu1–N1 2.008(2)
Cu01–N2 1.985 (4) Cu1–N2 2.010(2)
Cu01–N1 1.986 (4) Cu1–N3 1.984(2)
Cu01–O3 2.314 (4) Cu1–N4 1.981(2)
Cu02–N4 1.993 (4) Cu2–O2A 2.417(2)
Cu02–N3 1.997 (4) Cu2–O3 1.922(2)
Cu02–N5 2.016 (4) Cu2–O4 1.944(2)
Cu02–N6 2.021 (4) Cu2–N5 1.968(2)
Cu02–O4 2.416 (4) Cu2–N6 1.995(2)
N4–Cu02–N3 82.94 (16) N2–Cu1–N3 93.38(8)
N4–Cu02–O4 92.34 (15) N2–Cu1–N4 176.55(8)
N3–Cu02–O4 97.21 (15) N2–Cu1–O1B 85.95(7)
N5–Cu02–O4 85.92 (16) N3–Cu1–N4 83.54(7)
N6–Cu02–O4 94.32 (16) N4–Cu1–O1B 92.73(7)
N4–Cu02–N5 175.97 (17) N1–Cu1–N3 172.41(8)
N3–Cu02–N5 93.67 (16) N1–Cu1–N4 93.94(7)
N4–Cu02–N6 93.30 (16) N1–Cu1–O1B 93.06(7)
N3–Cu02–N6 168.00 (18) N3–Cu1–O1B 94.21(7)
N5–Cu02–N6 90.45 (16) N5–Cu2–N6 83.01(7)
O1–Cu01–O2 86.28 (14) O2A–Cu2–N5 88.27(6)
O1–Cu01–N2 95.40 (15) O2A–Cu2–N6 89.17(6)
O2–Cu01–N2 168.35 (16) O2A–Cu2–O3 98.01(6)
O1–Cu01–N1 174.31 (16) O2A–Cu2–O4 99.16(6)
O2–Cu01–N1 93.80 (15) O3–Cu2–N5 173.36(7)
N2–Cu01–N1 83.39 (16) O3–Cu2–N6 94.85(7)
O1–Cu01–O3 93.65 (14) O3–Cu2–O4 86.36(6)
O2–Cu01–O3 92.20 (14) O4–Cu2–N5 94.82(7)
N2–Cu01–O3 99.18 (15) O4–Cu2–N6 171.34(7)
N1–Cu01–O3 92.04 (15)
Fig. 2. ORTEP diagram of complex 3 showing 50% probability thermal ellipsoids
with atom labeling scheme for metal and heteroatoms.
Fig. 3. ORTEP view of complex 4 showing 50% probability thermal ellipsoids with
atom labeling scheme for the metal and heteroatoms.
Fig. 4. (a) Absorption spectral traces on addition of CT-DNA to the solution of 4
(40 M) (shown by arrow). Inset shows plot of (Deaf  Debf) vs. [DNA] for absorption
titration of CT-DNA with 4.
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DNA itself (Fig. 6(a), Table 1).
The DNA binding mode by the complexes was also studied by
the viscometric titration method. Viscosity of a DNA solution is
sensitive to the addition of compound which binds through by
intercalation; we examined the effect on the speciﬁc relative vis-
cosity of DNA upon addition of complexes, because the relative
speciﬁc viscosity (/0), ( and 0 are the speciﬁc viscosities of DNA inthe presence and absence of the complexes, respectively) of DNA
reﬂects the increase in contour length associated with separation
of DNA base pairs caused by complex binding. The relative viscos-
ity of DNA and contour length follows the equation: (/0) = (L/L0)1/3,
where L and L0 are the contour length of DNA in the presence and
absence of the complexes respectively. A classical intercalator such
as EB could cause a signiﬁcant increase in viscosity of DNA solu-
tions, in contrast, a partial and/or non-classical intercalation of
the ligand could bend or kink DNA resulting in a decrease in its
effective length with a concomitant increase in its viscosity [48].
The plots of relative viscosities with R = [Cu]/[DNA] are shown in
Fig. 6(b). The change in relative viscosity of dppz complex is more
Fig. 5. Emission spectral changes on addition of 4 to the CT-DNA bound to ethidium
bromide (shown by arrow). Inset: Effect of addition of metal complex [B = bpy 2
(.); phen 3 (d); dpq 4 (j), dppz 5 (N)] to the emission intensity CT-DNA-bound
ethidium bromide in a 5 mM Tris–HCl/5 mM NaCl buffer (pH 7.2) at 25 C.
Fig. 6. (a) Effect of addition of complexes (1–5) (20 lM) on the melting temper-
ature of CT-DNA (200 M) in 5 mM Phosphate buffer (pH 6.85) with a ramp rate of
0.5 C/min. (b) Change in relative speciﬁc viscosity of CT-DNA (150 lM) with
addition of complex bpy 2 (N); phen 3 (d); dpq 4 (j), dppz 5 (.)] in 5 mM Tris–HCl
buffer medium at 37 ± 0.1 C.
Fig. 7. Gel electrophoresis diagram showing the oxidative cleavage of SC pUC19
DNA (0.2 g), by the 10M complexes (1–5) in the presence of 500 M MPA in 50 mM
Tris–HCl/NaCl buffer (pH, 7.2). lane-1, DNA control; lane-2, DNA + 1; lane-3,
DNA + 2; lane-4, DNA + 3; lane-5, DNA + 4; lane-6, DNA + 5; lane-7, DNA + 1 + MPA;
lane-8, DNA + 2 + MPA; lane-9, DNA + 3 + MPA; lane-10, DNA + 4 + MPA; lane-11,
DNA + 5 + MPA.
Table 4
Selected DNA cleavage data for complex 5.
Lane No. Condition %NC
1 DNA control 2
2 DNA + MPA (200 mM) 3
3 DNA + 5 (10 lM) 6
4 DNA + MPA (200 mM) + 5 (10 lM) 98
5 DNA + MPA (200 mM) + NaN3 (500 lM) + 5 (10 lM) 89
6 DNA + MPA (200 lM) + TEMP (500 lM) + 5 (10 lM) 92
7 DNA + MPA (200 lM) + DABCO (500 lM) + 5 (10 lM) 97
8 DNA + MPA (200 lM) + KI (500 lM) + 5 (10lM) 32
9 DNA + MPA (200 lM) + DMSO (4 lL) + 5 (10lM) 57
10 DNA + MPA (200 lM) + D2O (14 lL) + 5 (10lM) 95
11 DNA + MPA (200 lM) + Catalase (4 units) + 5 (10lM) 42
12 DNA + MPA (200 lM) + SOD (4 units) + 5 (10lM) 90
13 DNA + MPA (200 lM) + distamycin (200 lM) + 5 (10 lM) 91
14 DNA + MPA (200 lM) + methyl green (200 lM) + 5 (10 lM) 34
Fig. 8. Mechanistic study of cleavage of SC pUC19 DNA (30 lM) by 5 in the
presence of MPA (5 mM) with various additives in Tris buffer (pH 7.2) medium.
Scheme 2. Proposed mechanistic pathway for the chemical nuclease activity of
complexes in Tris-buffer medium in presence of MPA.
P.R. Chetana et al. / Polyhedron 68 (2014) 172–179 177than the dpq, phen and bpy analogues suggesting high intercala-
tive binding propensity of the dppz complexes in comparison to
their analogues.
The DNA binding ability of copper complexes was essential to
mediate DNA cleavage when DNA-bound ROS acted as the direct
oxidative intermediates and higher DNA afﬁnity normally leads
to higher DNA cleavage efﬁciency [49]. Since polynuclear com-
plexes can enhance the afﬁnity to anionic DNA and enhance theirDNA cleavage activity. The DNA binding afﬁnity of the complexes
showed the following order 5 > 4 > 3 > 2 > 1. Phenanthroline and
its derived ligands viz., dpq, dppz are sterically compact due to
extended heterocyclic ring system and metal complexes with such
ligands have relatively shielded surfaces and help towards DNA-
complex non covalent binding [50,51].3.4. DNA cleavage studies
The oxidative DNA cleavage activity of the complexes in the
presence of reducing agent MPA (5 mM) is studied by agarose gel
electrophoresis using supercoiled (SC) plasmid pUC19 DNA (0.2 g,
30 M NP) in 50 mM Tris–HCl/50 mM NaCl buffer (pH, 7.2) and
the Copper (II) complexes (Fig. 7). Selected DNA cleavage data were
given in Table 4. Cu2+(aq) alone or with added MPA did not show
DNA cleavage activity.
The phen, dpq and dppz complexes show signiﬁcant ‘‘chemical
nuclease’’ activity. A 10 lM complex 3–5 shows almost complete
conversion of the SC (form I) to its nicked circular form (NC, form
Table 5
Minimum inhibitory concentration for complexes 1–5 and ligands (lg/mL).
Bacterial Strains 1 2 3 4 5 bpy phen Ampicillin*
Bacillus subtilis – >1000 – 350 450 – 450 16.0
Micrococcus luteus – 1000 – 425 500 500 1000 11.7
Staphylococcus aureus >1000 – – 475 450 – >1000 11.0
Streptococcus mutans – – 475 500 1000 >1000 19.8
E. coli – 20 – 1000 1000 – 500 7.2
Pseudomonas aeruginosa – – – 500 350 – 1000 18.7
Proteus vulgaris – – – 350 400 – 1000 NT
* Positive control, NT – not tested.
178 P.R. Chetana et al. / Polyhedron 68 (2014) 172–179II) of DNA. Mechanistic aspects of the chemical nuclease reactions
are performed using various control experiments (Fig. 8). In ab-
sence of complex, MPA or the ternary complexes showed no appar-
ent conversion of SC to its nicked-circular (NC) form. Complexes 5
displayed signiﬁcant reduction in the chemical nuclease activity in
the presence of methyl green, while similar inhibition for the com-
plexes 2 and 3 was observed in the presence of distamycin-A [52].
Addition of hydroxyl radical scavengers [53] like DMSO, catalase,
KI shows signiﬁcant inhibition of the DNA cleavage activity (lane
8, 9 and 11; Fig. 8, Table 4) of the complexes indicating the possi-
bility of the involvement of hydroxyl radical and/or ‘‘copper-oxo’’
intermediate as the reactive species. Addition of superoxide dis-
mutase (SOD) or singlet oxygen scavengers (lane 5, 6 and 7) does
not show any apparent effect on the DNA cleavage activity suggest-
ing the non-involvement of O2 or singlet oxygen in the cleavage
reactions [54]. No considerable inhibition of DNA cleavage was ob-
served in presence of sodium azide and as well as no enhancement
of DNA cleavage in the presence of D2O indicating the singlet oxy-
gen were not a reactive species in the scission reactions (Scheme 2).
MPA could form reduced Cu(I) species that can activate molecular
oxygen to generate OH radical following a mechanistic pathway
that is known for the chemical nuclease activity of bis-phen copper
species [1,55].
4. Antimicrobial activity
The antimicrobial activity of the complexes 1–5 ligands and
copper salt was evaluated against a panel of pathogenic bacterial
strains by disc diffusion and serial dilution method in aqueous/
DMF medium. The result obtained for zone inhibition exhibited
by the complexes and the ligands are summarized in Table S1.
The 5 and 4 shows highest zone of inhibition against B. subtilis,
M. luteus, S. aureus, S. mutans, E. coli, P. aeruginos and P. vulgaris
respectively. 1 shows highest zone of inhibition 31 mm against
E. coli compared with other complexes (Table S1). MIC values for
complexes 1–5 and ligands are summarized in Table 5. The 2
shows highest antibacterial activity against E. coli with MIC value
20 lg/mL. The minimum inhibitory concentration values revealed
that they have relatively better antibacterial activity compared to
ligands. This might be due to reduction in the polarity of metal
ion by partial sharing of its positive charge with the donor groups,
increasing lipophilic nature of the central metal ion and in turn
may favors its permeation to the lipid layer of the membrane.
The complexes 1–5 and ligands were screened against fungus Can-
dida albica observed no considerable activity under assay
conditions.
5. Conclusion
Four binuclear copper (II) complexes [Cu(oxpn)Cu(B)]2+ are
synthesized, characterized and their DNA interactions were stud-
ied. The novel complexes labelled as 3 and 4 are structurally char-
acterized by X-ray crystallography. The phen (3) complexcrystallizes in the monoclinic space group P21/c. The dpq (4) com-
plex crystallizes in the monoclinic space group P21/n. The results
suggest that the dpq and dppz complexes are avid binders to the
CT-DNA giving an order: (5) (dppz) > (4) (dpq) > (3) (phen) (2)
(bpy) > (1). Binuclear copper (II) complexes having DNA binding
phenanthroline bases and oxamide moiety show aerobic DNA
cleavage activity in presence of MPA. Complexes do not cleave
DNA under argon medium. The dppz complex due to its extended
conjugated aromatic planar surface, shows highest DNA cleavage
in presence of air and MPA, follows hydroxyl free radical pathway
and major groove binding. 2 exhibited highest antibacteria activity
against E. coli among the tested complexes.
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